MEDI
Harbor Health Care ETF
MEDI seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally.
Global
EQUITY
Active
MANAGEMENT STYLE
$ 28.3 M
ASSETS UNDER MGMT
80 bp
EXPENSES
Fund Basics
| Inception date | Nov 17, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ELI LILLY & CO | 20.7 % |
| ASCENDIS PHARMA A/S | 15.0 % |
| LEGEND BIOTECH CORPORATION SPONSORED ADR | 5.2 % |
| ABBVIE INC | 4.7 % |
| VAXCYTE, INC. | 4.6 % |
| INTUITIVE SURGICAL INC | 4.5 % |
| RHYTHM PHARMACEUTICALS, INC. | 3.8 % |
| INSMED INC | 3.6 % |
| ABIVAX SA-ADR | 3.5 % |
| DANAHER CORP | 2.4 % |
Constituent Breakdown
| Number of holdings | 41 |
| Herfindahl-Hirschman Index | 834 |
| Wgt avg mkt cap (mns) | $243,404 |
| Large cap (>$10bn) | 68.5% |
| Mid cap ($2-10bn) | 26.3% |
| Small cap (<$2bn) | 0.5% |
| Developed mkts. | 95.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 81.8 % |
 |
DENMARK | 16.2 % |
Historical Performance
Standardized Performance (as of 04/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -5.2% | 13.9% | 8.7% | 12.4% | -- | -- | -- | 12.7% |
| Dividend Yield | 0.0% | 0.0% | 0.3% | 0.9% | -- | -- | -- | 0.8% |
| Total Returns | -5.2% | 13.9% | 9.0% | 13.3% | -- | -- | -- | 13.5% | Ann. Volatility | 23.2% | 20.9% | 20.6% | 18.8% | -- | -- | -- | 18.6% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.75 | 20% |
| MSCI EAFE | 0.73 | 26% |
| MSCI Emg Mkts | 0.41 | 13% |
Liquidity Measures
| Avg. volume (000) | 6 |
| ADV traded (mns) | $0 |
| Turnover | 0.7% |
| Avg. Bid/Ask (% of price) | 0.21% |
Technical Indicators
| 30d moving avg. (EMA) | $29.99 |
| Relative strength (RSI) | 48 |
| MACD/Signal | 0.09/0.04 |
| Bollinger Bands (Upper/Lower) | $31.16/$29.01 |
| Short interest (% of AUM) | 0.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MEDI |
Expenses vs. MEDI |
ALTAR Score™ vs. MEDI |
|---|---|---|---|---|
| IYH | iShares U.S. Healthcare ETF | 33.7% | -40 bp | +7.4% |
| XLV | Health Care Select Sector SPDR | 33.0% | -72 bp | +8.2% |
| FHLC | Fidelity MSCI Health Care Index ETF | 32.9% | -72 bp | +6.8% |
| VHT | Vanguard Health Care ETF | 32.6% | -71 bp | +6.6% |
| HRTS | Tema Heart & Health ETF | 31.2% | -5 bp | +4.2% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 31.1% | -5 bp | +2.4% |
| PPH | VanEck Pharmaceutical ETF | 29.4% | -44 bp | +9.0% |
| FMED | Fidelity Disruptive Medicine ETF | 28.4% | -30 bp | -0.3% |
| IXJ | iShares Global Healthcare ETF | 26.2% | -38 bp | +7.9% |
| MEDX | Horizon Kinetics Medical ETF | 24.9% | +5 bp | +2.5% |
Risk and Returns: MEDI vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 5/15/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
-0.9%
ALTAR SCORE™
2nd
PERCENTILE
AVOID
ETFRC RATING
There are 584 funds in the Global Equity category with an average
ALTAR Score™ of 4.2% and a standard deviation
of 2.6%. MEDI's ALTAR Score™ is approximately -2.0 standard
deviations above the category average. This places MEDI in the 2nd percentile
among funds in the category.
Sell-Side Consensus
$39.43
PRICE TARGET
+29.0%
UPSIDE
Bid/Ask Spreads
21 bp
AVG SPREAD
14 —
121 bp
RANGE